⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4031160 | 0.71 | — | — | |
| SCHEMBL964277 | 0.71 | — | — | |
| SCHEMBL1227367 | 0.71 | — | — | |
| SCHEMBL749845 | 0.71 | — | — | |
| SCHEMBL601273 | 0.71 | — | — | |
| SCHEMBL8678617 | 0.69 | — | — | |
| SCHEMBL247513 | 0.67 | — | — | |
| SCHEMBL17599039 | 0.67 | — | — | |
| SCHEMBL9253616 | 0.67 | — | — | |
| SCHEMBL20432 | 0.65 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110319349-A1 | Methods for Reducing Platelet Activation and for the Treatment of Thrombotic Events | SCOTT ROBERT A D (US) | 2011-12-29 | — | — | US | disclosed |
| EP-1931355-A2 | METHODS FOR REDUCING PLATELET ACTIVATION AND FOR THE TREATMENT OF THROMBOTIC EVENTS | Atherogenics, Inc. (US) | 2008-06-18 | — | — | EP | disclosed |
| US-20070213303-A1 | Methods for reducing platelet activation and for the treatment of thrombotic events | CRABTREE ACQUISITION CO, LLC | 2007-09-13 | — | — | US | disclosed |
| WO-2007044726-A2 | METHODS FOR REDUCING PLATELET ACTIVATION AND FOR THE TREATMENT OF THROMBOTIC EVENTS | ATHEROGENICS, INC. (US) | 2007-04-19 | — | — | WO | disclosed |